IMPE Abstracts

Introduction: Most children born Small for Gestational Age (SGA) show catch-up growth during the first 2 years of life. However, one part remains with short stature, changes in body composition (lower lean mass), and metabolic disorders. Recombinant Growth Hormone (rGH) is approved for the treatment of short stature in children born SGA. In addition to promoting catch-up growth, rGH acts on body composition and metabolic profile. Objective: This study assessed...